SCHEMBL6034709

SCHEMBL6034709

CCCCCCCCCCCCCCOC(=O)CS(=O)(=O)O

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.62
RAD52 P43351 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
DGKA P23743 1/20 0.52
FAAH O00519 2/20 0.51
HTR2C P28335 1/20 0.50
EPHX1 P07099 1/20 0.48
TSHR P16473 3/20 0.47
PRSS1 P07477 1/20 0.45
PRSS2 P07478 1/20 0.45
PRSS3 P35030 1/20 0.45
HCAR2 Q8TDS4 1/20 0.44
DNM1 Q05193 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
ACHE P22303 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18140111 1.00 NAAA (0.62) NAAARAD52NPSR1DGKAFAAH
SCHEMBL8751921 1.00 NAAA (0.62) NAAARAD52NPSR1DGKAFAAH
SCHEMBL9437256 1.00 NAAA (0.62) NAAARAD52NPSR1DGKAFAAH
SCHEMBL18140142 1.00 NAAA (0.62) NAAARAD52NPSR1DGKAFAAH
SCHEMBL18140311 1.00 NAAA (0.62) NAAARAD52NPSR1DGKAFAAH
SCHEMBL6128331 1.00 NAAA (0.62) NAAARAD52NPSR1DGKAFAAH
SCHEMBL18139769 1.00 NAAA (0.62) NAAARAD52NPSR1DGKAFAAH
SCHEMBL334070 1.00 NAAA (0.62) NAAARAD52NPSR1DGKAFAAH
SCHEMBL7588972 1.00 NAAA (0.62) NAAARAD52NPSR1DGKAFAAH
SCHEMBL6116070 0.98 NAAA (0.60) NAAARAD52NPSR1DGKAFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220257487-A1 SULPHATE-FREE CONCENTRATED RHEO-FLUIDIFYING FOAMING COMPOSITION AND USES THEREOF Laboratoires de Biologie Végétale Yves Rocher (FR) 2022-08-18 US claimed
EP-3999022-A1 SULPHATE-FREE CONCENTRATED RHEO-FLUIDIFYING FOAMING COMPOSITION AND USES THEREOF Laboratoires De Biologie Vegetale Yves Rocher (FR) 2022-05-25 EP claimed
CN-114144162-A Sulfate-free concentrated rheological fluidized foaming composition and use thereof 畏斯罗契尔植物生物实验室 2022-03-04 CN claimed
WO-2021009445-A1 SULPHATE-FREE CONCENTRATED RHEO-FLUIDIFYING FOAMING COMPOSITION AND USES THEREOF Laboratoires de Biologie Végétale Yves Rocher (FR) 2021-01-21 WO claimed
US-20220257487-A1 SULPHATE-FREE CONCENTRATED RHEO-FLUIDIFYING FOAMING COMPOSITION AND USES THEREOF Laboratoires de Biologie Végétale Yves Rocher (FR) 2022-08-18 US disclosed
EP-3999022-A1 SULPHATE-FREE CONCENTRATED RHEO-FLUIDIFYING FOAMING COMPOSITION AND USES THEREOF Laboratoires De Biologie Vegetale Yves Rocher (FR) 2022-05-25 EP disclosed
CN-114144162-A Sulfate-free concentrated rheological fluidized foaming composition and use thereof 畏斯罗契尔植物生物实验室 2022-03-04 CN disclosed
WO-2021009445-A1 SULPHATE-FREE CONCENTRATED RHEO-FLUIDIFYING FOAMING COMPOSITION AND USES THEREOF Laboratoires de Biologie Végétale Yves Rocher (FR) 2021-01-21 WO disclosed
US-10428194-B2 Modified acrylic resin cured product, and laminate thereof, and production methods therefor MITSUI CHEMICALS, INC. (JP) 2019-10-01 US disclosed
EP-3263635-B1 MODIFIED ACRYLIC RESIN CURED PRODUCT, AND LAMINATE THEREOF, AND PRODUCTION METHODS THEREFOR MITSUI CHEMICALS INC (JP) 2019-09-18 EP disclosed
US-20180163056-A1 HYDROPHILIC CURABLE COMPOSITIONS MITSUI CHEMICALS, INC. (JP) 2018-06-14 US disclosed
US-20180030230-A1 MODIFIED ACRYLIC RESIN CURED PRODUCT, AND LAMINATE THEREOF, AND PRODUCTION METHODS THEREFOR MITSUI CHEMICALS, INC. (JP) 2018-02-01 US disclosed
EP-3263635-A1 MODIFIED ACRYLIC RESIN CURED PRODUCT, AND LAMINATE THEREOF, AND PRODUCTION METHODS THEREFOR Mitsui Chemicals, Inc. (JP) 2018-01-03 EP disclosed
US-20170209345-A1 DENTAL PROSTHESIS MITSUI CHEMICALS, INC. (JP) 2017-07-27 US disclosed
EP-3081578-A1 COMPOSITION FOR HYDROPHILIC CURED PRODUCT Mitsui Chemicals, Inc. (JP) 2016-10-19 EP disclosed
US-7153516-B2 Oil-in-water nanogel thickened by an oil phase and a silicone; self structured; difference in complex viscosity of at least about 10,000 poise under oscillation stress at 0-5,000 (dyne/ cm2); low levels of emulsifiers. COLOR ACCESS, INC. (US) 2006-12-26 US disclosed
US-20040115159-A1 Novel nanoemulsions TADLOCK CHARLES C (US) 2004-06-17 US disclosed
US-20030012759-A1 Ringing nanogel compositions COLOR ACCESS 2003-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170209345-A1 DENTAL PROSTHESIS CAD, OR10J3, PSMA3 NAAA 3105/4885RAD52 1933/4885NPSR1 4087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.